1. Home
  2. Non-Kannada film tickets cheaper from this weekend

Non-Kannada film tickets cheaper from this weekend

DHNS
June 28, 2017

Bengaluru, Jun 28: Tickets for non-Kannada films will be cheaper by 4% to 5% from July 1, once the Goods and Services Tax (GST) kicks in.

filmticket1

On the other hand, tickets for films in Kannada and Karnataka's regional languages (Tulu, Kodava, Byari and Konkani) will be dearer by 18% or 28%. Under the new regime, tickets priced at Rs 100 or less are taxed at 18%, while those priced at more than Rs 100 are taxed at 28%.

Under the GST, the maximum tax on tickets is 28%. Currently, non-Kannada films pay 32%. This means the tax on them decreases by 4%, resulting in lower ticket prices.

The GST Council can’t regulate ticket prices as it is left to the discretion of theatre owners. It can levy either 18% or 28%, based on ticket prices, regardless of categories such as dress circle and balcony. The new tax structure will not affect producers, distributors, exhibitors and theatre owners.

Finally, the audience will have to bear the additional burden, said K Raman, Joint Commissioner (Minor Act), Commercial Taxes Department.

Meanwhile, theatres without GST Council registration face closure. Under the new system, theatres with more than Rs 20 lakh in annual transactions should register. Theatres with a turnover of less than Rs 20 lakh are excluded from GST Council registration. About 400 theatres across the state are yet to get GST registration.

Some have less than Rs 20 lakh in transactions, while others are run on rent or lease. A few are partnerships. In the case of multiplexes, a single registration for multiple screens will do. “The government has given two months to the film industry to adopt the new system. Theatres without GST Council registration may not stop screening films immediately,” Vivek Mallya, an expert on GST, said.

filmticket2

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 5,2020

Tightening control over companies misleading advertisements of medicines and products, the Indian government could soon slap a fine of up to Rs10 lakh and up to two years' imprisonment. While repeat offender could be fined up to Rs50 and imprisonment up to five years.

The Ministry of Health and Family Welfare's new draft of the Drugs and Magic Remedies (Objectionable Advertisements) (Amendment) Bill, 2020, provides extremely stringent penalties compared to the current law.

Under the new Act, companies advertising medicines and products falsely claiming to make a person fairer, improve height and memory or cure issues like hair loss or greying and premature ageing, among several others, may attract more stringent fines and jail time.

The current Act, 1954, leaves scope for companies to create deceptive advertisements as first time offender can be jailed for six months while repeat offender can be up to one year in prison, reported The Indian Express.

Under the Bill, deceptive advertisements will cover digital advertising, notice, circular, label, wrapper, invoice, banner and poster, among others. The government also plans to expand the scope of the law under the proposed amendments to cover 24 more deceptive claims not included in the current law, like medicines that can cure AIDS, change the sex of a foetus, among others, reported Livemint.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 13,2020

Bengaluru, Mar 13: Karnataka Health Department is planning to set up a separate hospital for COVID-19 so that the affected can be kept in quarantine at one place.

Presently, it is in the process of setting up separate isolation wards for COVID-19 cases at eight Bengaluru hospitals.

Minister for Medical Education K Sudhakar said on Friday that he has already discussed the idea of a separate facility for COVID-19 cases, so that those isolated, can be kept at a single location to contain the spread of the virus.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 10,2020

Bengaluru, Mar 10: With concerns growing by the day, the Karnataka government is readying three more labs to test throat swab samples.

Currently, only two labs in Bengaluru — National Institute of Virology and Virus Research and Diagnostics Laboratory (VRDL) lab attached to Bangalore Medical College and Research Institute — are categorised biosafety level 2+, a requirement for coronavirus tests.

Now, the government is working on upgrading three more labs, one each in the government medical colleges at Hassan, Mysuru and Shivamogga. “The labs will be ready within one week,” the authorities said.

Currently, the labs are testing only throat swab samples of suspected patients and taking 24 hours to give the results. “A patient’s blood sample will be collected only if he or she tests positive for covid-19 infection in the first throat swab sample.

While earlier the state would send all samples of suspected coronavirus cases to NIV, Pune, the two labs were upgraded to biosafety level 2+ in mid-February.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.